62 citations · 71 across the 5 of their papers we have counts for
6 papers
Estimation of the odds ratio in a proportional odds model with censored time-lagged outcome in a randomized clinical trial
Anastasios A. Tsiatis, Marie Davidian, Shannon T. Holloway
In many randomized clinical trials of therapeutics for COVID-19, the primary outcome is an ordinal categorical variable, and interest focuses on the odds ratio (active agent vs. co…
Estimating Vaccine Efficacy Over Time After a Randomized Study is Unblinded
Anastasios A. Tsiatis, Marie Davidian
The COVID-19 pandemic due to the novel coronavirus SARS CoV-2 has inspired remarkable breakthroughs in development of vaccines against the virus and the launch of several phase 3 v…
Sample Size Calculations for SMARTs
Eric J. Rose, Eric B. Laber, Marie Davidian +3
Sequential Multiple Assignment Randomized Trials (SMARTs) are considered the gold standard for estimation and evaluation of treatment regimes. SMARTs are typically sized to ensure…
Interpretable Dynamic Treatment Regimes
Yichi Zhang, Eric B. Laber, Anastasios Tsiatis +1
Precision medicine is currently a topic of great interest in clinical and intervention science. One way to formalize precision medicine is through a treatment regime, which is a se…
Using Decision Lists to Construct Interpretable and Parsimonious Treatment Regimes
Yichi Zhang, Eric B. Laber, Anastasios Tsiatis +1
A treatment regime formalizes personalized medicine as a function from individual patient characteristics to a recommended treatment. A high-quality treatment regime can improve pa…
Comment: Demystifying Double Robustness: A Comparison of Alternative Strategies for Estimating a Population Mean from Incomplete Data
Anastasios A. Tsiatis, Marie Davidian
Comment on ``Demystifying Double Robustness: A Comparison of Alternative Strategies for Estimating a Population Mean from Incomplete Data'' [arXiv:0804.2958]